Advertisement
Screener

Deciphera Pharmaceuticals, Inc. Patents: Applications Pending, 2018

Deciphera Pharmaceuticals, Inc. Patent Applications Pending

3 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2018-12-28: Application 62786105; Invention METHODS OF TREATING DISORDERS USING CSF1R INHIBITORS; Applicant Deciphera Pharmaceuticals, LLC; Status Provisional Application Expired.
  • 2018-01-31: Application 62624453; Invention COMBINATION THERAPY FOR THE TREATMENT OF MASTOCYTOSIS; Applicant Deciphera Pharmaceuticals, LLC; Status Provisional Application Expired.
  • 2018-01-31: Application 62624448; Invention COMBINATION THERAPY FOR THE TREATMENT OF GASTROINTESTINAL STROMAL TUMORS; Applicant Deciphera Pharmaceuticals, LLC; Status Provisional Application Expired.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2018-12-2862786105METHODS OF TREATING DISORDERS USING CSF1R INHIBITORSDeciphera Pharmaceuticals, LLCProvisional Application Expired
Daniel L. Flynn
Bryan D. Smith
Rodrigo Ruiz Soto
Keisuke Kuida
United States
United States
United States
United States
2018-01-3162624453COMBINATION THERAPY FOR THE TREATMENT OF MASTOCYTOSISDeciphera Pharmaceuticals, LLCProvisional Application Expired
Daniel L. FLYNN
Bryan D. SMITH
Anu GUPTA
United States
United States
United States
2018-01-3162624448COMBINATION THERAPY FOR THE TREATMENT OF GASTROINTESTINAL STROMAL TUMORSDeciphera Pharmaceuticals, LLCProvisional Application Expired
Daniel L. Flynn
Bryan D. Smith
Anu Gupta
United States
United States
United States